Mayne Pharma reports $383.7M in annual revenue
Mayne Pharma (ASX:MYX) reported $86.5 million in fourth-quarter revenue and $383.7 million in full-year revenue for fiscal year 2026.
Mayne Pharma (ASX:MYX) reported $86.5 million in fourth-quarter revenue and $383.7 million in full-year revenue for fiscal year 2026.
Bryan Ma, Vice President of Devices Research at IDC, discusses Apple's latest earnings and the outlook for the broader consumer electronics market. He speaks with Shery Ahn on Bloomberg: The Asia Trade.
Advanced Innergy (ASX:AIH) reduced its full-year earnings guidance following project delays and supply-chain pressures.
Origin Energy (ASX:ORG) reported full-year production of 668 PJ alongside $911 million in fully franked dividends for the period ended June 30.
Fortescue (ASX:FMG) delivered record total iron ore shipments of 201.3 million tonnes for the 2026 financial year.
Monadelphous Group (ASX:MND) secured an approximate $165 million contract with Rio Tinto (ASX:RIO) for design and construction.
Novatti Group (ASX:NOV) reported group revenue of $3.7 million for the fourth quarter of fiscal 2026.
Union members at BHP (ASX:BHP) held a meeting on July 30 and endorsed a 24-hour freeze on ship loading and port activity for Aug. 9.
Capstone Copper (ASX:CSC) reported a record revenue of US$739.7 million for the second quarter of 2026.
Aspermont (ASX:ASP) posted total continuing revenue of $4.5 million for the quarter ended June 30.
Anthony Albanese and Chris Minns are negotiating a multi-million-dollar rescue package to keep Rio Tinto (ASX:RIO) Tomago operating past 2028.
Michael Hill International (ASX:MHJ) reported group sales of $654.7 million for the 52-week period ended June 28.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade